ZA873743B - Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon - Google Patents
Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferonInfo
- Publication number
- ZA873743B ZA873743B ZA873743A ZA873743A ZA873743B ZA 873743 B ZA873743 B ZA 873743B ZA 873743 A ZA873743 A ZA 873743A ZA 873743 A ZA873743 A ZA 873743A ZA 873743 B ZA873743 B ZA 873743B
- Authority
- ZA
- South Africa
- Prior art keywords
- cell carcinoma
- recombinant human
- basal cell
- intralesionally
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86664486A | 1986-05-27 | 1986-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA873743B true ZA873743B (en) | 1987-11-25 |
Family
ID=25348060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA873743A ZA873743B (en) | 1986-05-27 | 1987-05-25 | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0248583B1 (ko) |
JP (1) | JPS62289526A (ko) |
KR (1) | KR870010871A (ko) |
AT (1) | ATE100717T1 (ko) |
AU (1) | AU601741B2 (ko) |
CA (1) | CA1295243C (ko) |
DE (1) | DE3788899T2 (ko) |
DK (1) | DK264787A (ko) |
ES (1) | ES2061496T3 (ko) |
IE (1) | IE62318B1 (ko) |
IL (1) | IL82654A0 (ko) |
PH (1) | PH26198A (ko) |
ZA (1) | ZA873743B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
EP0278715A3 (en) * | 1987-02-09 | 1989-03-08 | Schering Corporation | Use of human gamma interferon for treatment of basal cell carcinoma |
EP0446279A1 (en) * | 1988-12-01 | 1991-09-18 | Schering Corporation | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
US5256410A (en) * | 1988-12-01 | 1993-10-26 | Schering Corporation | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
WO1992011025A2 (en) * | 1990-12-21 | 1992-07-09 | Schering Corporation | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
EP3600379B1 (en) | 2017-03-31 | 2022-12-21 | Accanis Biotech F&E GmbH & Co KG | Prevention and treatment of non-melanoma skin cancer (nmsc) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0305551A3 (en) * | 1981-10-13 | 1990-01-10 | Exovir, Inc. | Pharmaceutical compositions for topical application |
WO1983002460A1 (en) * | 1982-01-15 | 1983-07-21 | Cetus Corp | Interferon-alpha 74 |
US5098703A (en) * | 1982-01-15 | 1992-03-24 | Cetus Corporation | Interferon-alpha 76 |
AU1153083A (en) * | 1982-01-15 | 1983-07-28 | Cetus Corporation | Interferon-alpha 54 |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
-
1987
- 1987-05-25 ZA ZA873743A patent/ZA873743B/xx unknown
- 1987-05-25 PH PH35292A patent/PH26198A/en unknown
- 1987-05-25 IE IE135887A patent/IE62318B1/en not_active IP Right Cessation
- 1987-05-25 CA CA000537837A patent/CA1295243C/en not_active Expired - Fee Related
- 1987-05-25 AU AU73366/87A patent/AU601741B2/en not_active Ceased
- 1987-05-25 DK DK264787A patent/DK264787A/da not_active Application Discontinuation
- 1987-05-26 JP JP62129563A patent/JPS62289526A/ja active Pending
- 1987-05-26 DE DE87304642T patent/DE3788899T2/de not_active Expired - Fee Related
- 1987-05-26 ES ES87304642T patent/ES2061496T3/es not_active Expired - Lifetime
- 1987-05-26 KR KR870005198A patent/KR870010871A/ko not_active Application Discontinuation
- 1987-05-26 IL IL82654A patent/IL82654A0/xx not_active IP Right Cessation
- 1987-05-26 EP EP87304642A patent/EP0248583B1/en not_active Expired - Lifetime
- 1987-05-26 AT AT87304642T patent/ATE100717T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS62289526A (ja) | 1987-12-16 |
IL82654A0 (en) | 1987-11-30 |
DK264787A (da) | 1987-11-28 |
AU601741B2 (en) | 1990-09-20 |
EP0248583A2 (en) | 1987-12-09 |
IE871358L (en) | 1987-11-27 |
DE3788899D1 (de) | 1994-03-10 |
IE62318B1 (en) | 1995-01-25 |
CA1295243C (en) | 1992-02-04 |
EP0248583A3 (en) | 1989-10-18 |
ATE100717T1 (de) | 1994-02-15 |
DE3788899T2 (de) | 1994-05-05 |
PH26198A (en) | 1992-03-18 |
EP0248583B1 (en) | 1994-01-26 |
DK264787D0 (da) | 1987-05-25 |
KR870010871A (ko) | 1987-12-18 |
AU7336687A (en) | 1987-12-03 |
ES2061496T3 (es) | 1994-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ212632A (en) | Tumor necrosis factor, its preparation and its use | |
DK0433827T3 (da) | Cytotoksisk lumfocytmodningsfaktor | |
NO176665C (no) | Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav | |
IT1183181B (it) | Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione | |
GR3031927T3 (en) | Cysteine depleted il-6 muteins | |
NZ227944A (en) | Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide | |
ZA873743B (en) | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon | |
DE3773295D1 (de) | Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen. | |
DK0643973T3 (da) | Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi | |
HK46196A (en) | Treatment of leukocyte dysfunction with gm-csf | |
ES2115582T3 (es) | Preparacion y aplicaciones de interferon-gamma. | |
ZA884262B (en) | Pharmaceutical composition for the treatment of tumors | |
GB2179858B (en) | Compositions for treating viral skin diseases. | |
ZA899113B (en) | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon | |
IL84080A0 (en) | Human leukocyte interferon compositions for skin treatment | |
GR3006999T3 (ko) | ||
EP0278715A3 (en) | Use of human gamma interferon for treatment of basal cell carcinoma | |
HU900202D0 (en) | Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer | |
GR3003132T3 (en) | Pharmaceutical compositions having healing activity |